What is Chrono-log?
Chrono-log operates at the intersection of hematology and clinical diagnostics, specializing in the design, development, and manufacturing of advanced platelet function testing technologies. The company provides a comprehensive suite of aggregation systems, reagents, and laboratory supplies essential for the precise diagnosis of platelet function defects. By enabling clinicians to monitor anti-platelet drug efficacy and assess risks associated with thrombosis or bleeding, Chrono-log plays a pivotal role in optimizing patient outcomes and reducing systemic healthcare expenditures. Their integrated approach serves both research institutions and diagnostic laboratories, establishing the firm as a primary source for high-fidelity platelet analysis tools.
How much funding has Chrono-log raised?
Chrono-log has raised a total of $483K across 2 funding rounds:
Debt
$150K
Debt
$333K
Debt (2020): $150K with participation from PPP
Debt (2021): $333K led by PPP
Key Investors in Chrono-log
PPP
Public-Private Partnership
What's next for Chrono-log?
With the recent infusion of capital, Chrono-log is well-positioned to accelerate its late-stage growth initiatives. The strategic focus will likely shift toward scaling manufacturing capabilities to meet rising global demand for diagnostic precision and expanding the reach of their proprietary aggregation systems. As the company navigates this mature phase of its lifecycle, the emphasis remains on enhancing clinical utility and integrating new therapeutic monitoring capabilities into their existing product ecosystem. This financial backing provides the necessary runway to sustain long-term research and development efforts, ensuring that Chrono-log remains at the forefront of platelet function diagnostics while navigating the complexities of the modern healthcare regulatory landscape.
See full Chrono-log company page
